changing your setting. We'll assume that you are happy to receive all cookies on the BTG website.
Certain BTG products may not be available within the chosen location and indications may differ from your country's approved use.
For Medical questions regarding any BTG products, please contact firstname.lastname@example.org
DC Bead™ with doxorubicin for the local treatment of tumours in patients with hepatocellular carcinoma
The literature references provided in this bibliography were evaluated for safety and performance, as well as state of the art application. Case reports are included if a specific safety issue was reported. Literature reporting the concomitant use of doxorubicin loaded DC Bead™ with other therapies appear in the Combination Therapy section.
Note regarding the impact factor of each journal:
The impact factors were obtained from the Research Gate website on 05-December-2018, https://www.researchgate.net/publication/326016068_2018_Journal_Impact_Factor_2018/download. The downloaded pdf was entitled: “2018JournalImpactFactor.” Impact factors noted as ‘unknown’ were not found in the 2018 Journal Impact Factor document.
Select CONTINUE to proceed to the BTG website or LEAVE to learn more at BSC.com